Comprehensive review articles discussed the estrogens and their receptors in influencing the development as well as microenvironment of lung cancers and the significance of clinical studies exploring the anti-estrogen/anti-ER therapy usefulness against lung cancers (Table 2) [141,142]. This evidence concerns the gene ESR1 and lung carcinoma.